Neurological Disorders
Ongoing research evaluating novel treatments for multiple sclerosis and epilepsy, with studies focusing on both relapsing and progressive forms of MS, as well as various types of seizure disorders.
- Multiple Sclerosis Treatments
- Epilepsy Management
- Seizure Control Studies
Multiple trials testing new compounds like tolebrutinib and fenebrutinib for long-term disease management.
Cardiovascular Health
Studies focusing on preventing cardiovascular events and managing atherosclerotic disease, with particular attention to high-risk patients and post-stroke care.
- Stroke Prevention
- Heart Attack Prevention
- Atrial Fibrillation Management
Innovative therapies being tested to reduce major adverse cardiovascular events and improve patient outcomes.
Inflammatory Conditions
Research targeting inflammatory bowel diseases, including studies on Crohn’s Disease and ulcerative colitis, testing new therapeutic approaches.
- Gastrointestinal Disorders
- Nasal Polyps Treatment
- Autoimmune Conditions
Evaluating combination therapies and novel compounds for moderate to severe disease states.
